CareDx President and CEO Sells 19,000 Shares for $412,000

Transaction worth based connected SEC Form 4 weighted mean acquisition terms ($21.16); post-transaction worth calculated utilizing Jan. 22, 2026 marketplace close.

• How worldly was this transaction comparative to anterior insider sales?
  This merchantability of 19,480 shares was the largest among the 2 caller sell-only trades by John Hanna, surpassing the anterior transaction of 10,156 shares and exceeding the caller median sell-only commercialized size of 14,818 shares.

• What was the interaction connected the insider's ownership and does nonstop ownership stay significant?
  The transaction reduced nonstop holdings by 3.16%, leaving Hanna John Walter Jr with 597,405 straight held shares, which inactive represents a important ownership presumption post-sale.

• Did the transaction impact immoderate indirect entities oregon derivative instruments?
  No; each shares were held and sold directly, with nary engagement of options, household trusts, oregon different indirect ownership structures, and nary gifts oregon withholdings reported.

• Was the transaction apt influenced by capableness constraints oregon trading plan?
  The reduced holdings since April 2024 bespeak that disposable capableness was a applicable origin successful determining commercialized magnitude, and the transaction size exceeded the caller median sell-only commercialized but aligns with disposable capacity.

* 1-year show calculated utilizing Jan. 22, 2026 arsenic the notation date.

• CareDx offers diagnostic solutions for transplant patients, including AlloSure (kidney, heart, lung), AlloMap Heart, TruSight HLA, Olerup SSP, QTYPE, Ottr software, AlloSeq merchandise line, and diligent absorption tools.

• The institution generates gross done nonstop income and third-party organisation of proprietary diagnostic tests, bundle platforms, and related services tailored to organ and stem compartment transplant monitoring and management.

• Primary customers see transplant centers, hospitals, objective laboratories, and healthcare providers serving organ and stem compartment transplant recipients worldwide.

CareDx is simply a healthcare diagnostics institution specializing successful precocious molecular and integer solutions for transplant diligent care. Leveraging proprietary technologies and a diversified merchandise suite, the institution addresses captious needs successful organ and stem compartment transplant monitoring. Its strategical absorption connected innovation and integration crossed diagnostics and diligent absorption platforms positions CareDx arsenic a starring spouse for transplant centers and healthcare providers globally.